Format

Send to

Choose Destination
Br J Haematol. 2003 Sep;122(6):911-4.

Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model.

Author information

1
Department of Haematology, General Hospital St Georg, Hamburg, and Institute of Immunology, University of Kiel, Kiel, Germany.

Abstract

Survivin is overexpressed in several types of haematological malignancies making it an attractive target for therapeutic cytotoxic T-lymphocyte responses. Here, we identify two peptide epitopes derived from the murine survivin protein and demonstrate that Balb/c mice treated with syngeneic dendritic cells pulsed with the survivin epitopes were able to reject an otherwise lethal tumour inoculation of the A20 lymphoma. For the first time, these data provide evidence for the use of survivin peptide epitopes in T cell-based immunotherapeutic concepts against a B-cell lymphoma in vivo.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center